ESPERION THERAPEUTICS INC (ESPR) Stock Cash Flow
NASDAQ:ESPR - Nasdaq - US29664W1053 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -86.77M | -209.25M | -233.66M | -269.11M | -143.55M | |||
| Depreciation Amortization | 40.00K | 164.00K | 500.00K | 610.00K | 550.00K | |||
| Change In Working Capital | -35.27M | 13.68M | -3.37M | -52.51M | -4.26M | |||
| Other non cash items | 96.23M | 59.92M | 61.71M | 57.20M | 62.09M | |||
| OPERATING CASH FLOW | -25.76M | -135.49M | -174.83M | -263.81M | -85.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -13.37M | |||
| Other Investing Activity | 0.00 | 42.50M | 8.10M | -50.48M | 34.73M | |||
| INVESTING CASH FLOW | -317.00K | 42.50M | 8.10M | -50.48M | 21.36M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 280.00M | |||
| Stock Issued/Repurchased | 115.11M | 65.97M | 90.85M | 222.45M | -48.37M | |||
| Other Financing Activity | -59.15M | -15.51M | -58.24M | 45.77M | -29.91M | |||
| FINANCING CASH FLOW | 55.96M | 50.46M | 32.61M | 268.22M | 201.73M | |||
| CHANGE IN CASH | 29.88M | -42.53M | -134.12M | -46.07M | 137.91M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.76M | -135.49M | -174.83M | -263.81M | -85.18M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -13.37M | |||
| FREE CASH FLOW | -26.08M | -135.49M | -174.83M | -263.81M | -98.55M | |||
All data in USD